Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy.
about
American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adultsRoutine deprescribing of chronic medications to combat polypharmacySystematic review of clinical practice guidelines recommendations about primary cardiovascular disease prevention for older adultsHealth outcomes associated with polypharmacy in community-dwelling older adults: a systematic reviewAgeing and the epidemiology of multimorbidityDeprescription: The prescription metabolismA predictive in vitro model of the impact of drugs with anticholinergic properties on human neuronal and astrocytic systemsWhat are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi processMethodology for Developing Deprescribing Guidelines: Using Evidence and GRADE to Guide Recommendations for DeprescribingValidation of prescribing appropriateness criteria for older Australians using the RAND/UCLA appropriateness methodCooperation between geriatricians and general practitioners for improved pharmacotherapy in home-dwelling elderly people receiving polypharmacy - the COOP Study: study protocol for a cluster randomised controlled trial.Supporting medication discontinuation: provider preferences for interventions to facilitate deprescribing.Minimizing anticholinergic drug prescribing in older hospitalized patients: a full audit cycleOptimizing polypharmacy among elderly hospital patients with chronic diseases--study protocol of the cluster randomized controlled POLITE-RCT trial.Discontinuing inappropriate medication in nursing home residents (DIM-NHR Study): protocol of a cluster randomised controlled trialGuiding principles for the care of older adults with multimorbidity: an approach for clinicians: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity.Polypharmacy in chronic diseases-Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support (PRIMA-eDS): study protocol for a randomized controlled trialDeprescribing in Frail Older People: A Randomised Controlled Trial.The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis.Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process.Strategies to support recruitment of patients with life-limiting illness for research: the Palliative Care Research Cooperative Group.Predictors of nonpharmacological and pharmacological treatments stopped and started among nursing home residents with dementia.Prevalence of unplanned hospitalizations caused by adverse drug reactions in older veteransPatient-centered care for older adults with multiple chronic conditions: a stepwise approach from the American Geriatrics Society: American Geriatrics Society Expert Panel on the Care of Older Adults with MultimorbidityBarricades and brickwalls--a qualitative study exploring perceptions of medication use and deprescribing in long-term care.Medication adherence to multidrug regimens.Reducing Polypharmacy from the Perspectives of General Practitioners and Older Patients: A Synthesis of Qualitative Studies.A Delphi process to address medication appropriateness for older persons with multiple chronic conditions.Challenges and Enablers of Deprescribing: A General Practitioner Perspective.Effect of a patient-centered drug review on polypharmacy in primary care patients: study protocol for a cluster-randomized controlled trialSystems to identify potentially inappropriate prescribing in people with advanced dementia: a systematic review.Organising medication discontinuation: a qualitative study exploring the views of general practitioners toward discontinuing statins.Patients' perception of types of errors in palliative care - results from a qualitative interview study.Indication for pharmacological treatment is often lacking: a cross-sectional study on the quality of drug therapy among the elderlyQuinine induced simvastatin toxicity through cytochrome inhibition - a case report.Factors influencing deprescribing for residents in Advanced Care Facilities: insights from General Practitioners in Australia and Sweden.Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial.Year in review: medication mishaps in the elderly.Effectiveness of Interventions to Deprescribe Inappropriate Proton Pump Inhibitors in Older Adults.Remaining Life Expectancy With and Without Polypharmacy: A Register-Based Study of Swedes Aged 65 Years and Older.
P2860
Q24620909-86B6F46D-6975-4A89-AA13-E1EE26691223Q26775802-CF705CF0-478A-4234-9D84-9614337E4EA8Q26796403-1A173F84-E702-4F80-A5DC-6DF5CFC63AC6Q26821828-F095252B-1C1F-41AC-A6C4-62230252586CQ27012096-8B6931D7-AB3F-4386-BA1A-C406C5A9EC71Q28070294-1FBF0589-1A44-4D60-889E-F0D11F66E64AQ28543817-8B0FF49B-B627-4C35-877A-CA2F8A75FC25Q28545785-FFBAB56B-4C19-431C-8CAA-E365C617D40BQ28553495-44C1A411-ABC7-4BC9-AC7D-477AF852B3BDQ30525580-030CE95A-88CC-47F3-8A1D-D5802E15754EQ30843968-108380E0-CD19-4A04-865F-4ACA962648AFQ33850642-6635C362-B18D-481B-B8C5-88E97124C14FQ33949454-87A7BA38-6838-4648-BC36-DBB7692C51E6Q34316741-5021414E-A202-4164-A863-2E6E0C73706FQ34327516-D9F6DFA4-685C-44E6-A384-90F973EE2908Q34418562-16F4BD0B-AED1-4D30-ADA4-F56376CC6E72Q34511248-B2D9AE34-5308-4425-B417-47078E6CF141Q34516940-7879E2A3-983A-4D39-A040-4AE1FE043680Q34522113-E2B30E96-4E17-4728-9742-E9074CBC5941Q34554391-18BAC3A2-E048-47AA-8618-836E25F1C274Q34561028-69065FC8-2862-49A1-B120-04FD42348950Q35629279-FEE027CA-CDBF-4920-97AE-4C3E1F65A29CQ35672725-6150B840-DB56-4C96-899E-737C1FBC6D21Q35695252-FF9F73AD-A174-413E-BA11-6CB9BAB83681Q35894338-C613B8DF-B7A4-4B41-8631-8DB963EF8578Q35910780-2D3D0F15-21A5-42D2-BFF1-E9630BE69FC6Q35935867-603C1F74-462B-45E0-95FE-E15E53F9B2DBQ35958454-2250E0F1-115C-4612-AEAF-E396F18F6DD8Q35993718-9406F642-CE37-4CF1-8776-9B37AD140D6AQ35997093-F8980EC1-EDBF-454E-8854-6E1DAB646793Q36035333-2F059A81-BE25-423E-A83C-5CCA37C1A086Q36070018-620D4C44-A09A-4003-B4E4-140AD525C224Q36102259-2B45D207-E355-45FE-BBCA-FF244C6AE15EQ36142782-FEA21308-1F75-437A-8B2E-74F4A6AECC2EQ36156619-CEFC8D6F-F13C-496B-AA4A-FD394D1B8C7CQ36183123-7C006216-1F6E-4979-9216-A6666610DBDEQ36200626-DBE5A0AF-1453-43D4-8C0B-430DD7780848Q36278264-C77B1E5D-D7EE-40B5-BDF6-7ABB4D4F8EDFQ36285871-7617ABC5-E4C3-4988-858A-17308B649876Q36425738-C46375AE-D390-4CEB-8387-C8A955E9D12B
P2860
Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Feasibility study of a systema ...... ults: addressing polypharmacy.
@en
Feasibility study of a systema ...... ults: addressing polypharmacy.
@nl
type
label
Feasibility study of a systema ...... ults: addressing polypharmacy.
@en
Feasibility study of a systema ...... ults: addressing polypharmacy.
@nl
prefLabel
Feasibility study of a systema ...... ults: addressing polypharmacy.
@en
Feasibility study of a systema ...... ults: addressing polypharmacy.
@nl
P1476
Feasibility study of a systema ...... ults: addressing polypharmacy.
@en
P2093
Doron Garfinkel
P304
P356
10.1001/ARCHINTERNMED.2010.355
P407
P577
2010-10-01T00:00:00Z